Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine in the managed care environment.

Gary M Owens1

  • 1Medical Management and Policy, Independence Blue Cross, Philadelphia, Pennsylvania, USA.

The American Journal of Managed Care
|August 13, 2005
PubMed
Summary

Botulinum toxin may offer an alternative for migraine prophylaxis, but evidence is inconsistent. Managed care coverage varies, often requiring failure of conventional treatments due to mixed results and potential side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare Resource Utilization and Cost After Temperature-Controlled Radiofrequency Treatment of Nasal Airway Obstruction: A Real-World Longitudinal Claims Analysis.

International forum of allergy & rhinology·2025
Same author

Rethinking heart failure: patient classification and treatment.

The American journal of managed care·2022
Same author

Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.

American health & drug benefits·2022
Same author

Idiopathic pulmonary fibrosis: exploring the clinical and economic implications of the evolving treatment landscape.

The American journal of managed care·2021
Same author

Systemic sclerosis with associated interstitial lung disease: management considerations and future directions.

The American journal of managed care·2021
Same author

The spectrum of progressive fibrosis interstitial lung disease: clinical and managed care considerations.

The American journal of managed care·2021

Area of Science:

  • Neurology
  • Pharmacology
  • Health Policy

Background:

  • Migraine headaches pose significant clinical and economic challenges.
  • Current prophylactic treatments for frequent or intractable migraines lack consensus and may have side effects.
  • Botulinum toxin is being explored as a potential alternative for migraine prophylaxis.

Purpose of the Study:

  • To evaluate the efficacy and safety of botulinum toxin for migraine prophylaxis.
  • To examine the current landscape of managed care coverage for botulinum toxin in migraine treatment.

Main Methods:

  • Review of existing evidence on botulinum toxin for migraine prophylaxis.
  • Analysis of managed care policies regarding botulinum toxin coverage for migraine.

Main Results:

  • Evidence for botulinum toxin's effectiveness in migraine prophylaxis is inconsistent.
  • Managed care policies for botulinum toxin vary, with many not approving it as a first-line treatment.
  • Coverage is often limited to patients unresponsive or intolerant to conventional therapies.

Conclusions:

  • Botulinum toxin shows potential for migraine prophylaxis with minimal side effects, but further research is needed.
  • Managed care's cautious approach reflects the inconsistent evidence and highlights the need for clear treatment guidelines.

Related Experiment Videos